Meet The Team

Dr Damian Deavall

PhD

Damian is a project leader with notable expertise in global drug development, gained over more than 20 years. He has led the nonclinical safety assessment of 50+ candidate drugs encompassing a wide range of modalities (small molecules, antibodies, peptides, oligonucleotides, therapeutic viruses and vaccines) in multiple therapy areas, including oncology, infectious disease and metabolic disorders. Damian has contributed to drug development at every phase, from discovery, through clinical trials to marketing approval applications in EU and US. He leads and manages drug safety programs for biotech and larger pharma clients, bringing a pragmatic and considered approach to those collaborations, which teams greatly appreciate.